Advertisement

Topics

Aastrom Biosciences Incorporated Company Profile

17:45 EST 20th November 2017 | BioPortfolio

Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for cancer and other diseases and cells used in the restoration of normal tissues.



The Company has received approval to affix the CE Mark to the various components of the AastromReplicell™ System, the SC-I Therapy Kit for the production of bone marrow cells and the CB-I Therapy Kit for the production of umbilical cord blood cells. The Company plans to market its products through strategic corporate partnerships and other alliances.

Location

24 FRANK LLOYD WRIGHT DRIVE
PO BOX 376
Ann Arbor
MI
48106
United States of America

Contact

Phone: 734-930-5777
Fax: 734 665 0485


News Articles [569 Associated News Articles listed on BioPortfolio]

Harmony Biosciences gains US rights to pitolisant; raises $270 million

USA-based Harmony Biosciences, a part of the Paragon Biosciences corporate family, has acquired the exclusive…

Ricerca Biosciences, LLC Renamed to Concord Biosciences, LLC After Sale of Chemical Development ...

According to Clifford W. Croleyof Main Market Partners and the CEO of Concord Biosciences, "We are very pleased to focus our complete energies Read more...

Apricus Biosciences, Inc.: Apricus Biosciences to Present at the 2017 BIO Investor Forum

SAN DIEGO, 2017-10-10 13:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo ...

http://dailystocktracker.com/register/ Apricus Biosciences  On Tuesday, shares in San Diego, Californiaheadquartered Apricus Biosciences Inc. recorded a trading volume of 128,247 shares. The stoc...

Head to Head Survey: DARA Biosciences

DARA Biosciences and Mallinckrodt PLC are both specialty & advanced pharmaceuticals companies, but which is the superior investment? We will contrast the two companies based on the strength of the...

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

Reviewing Catalyst Biosciences

Catalyst Biosciences and Fortress Biotech are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valu...

Catalyst Biosciences and Mosaic Biosciences Enter into Strategic Collaboration to Develop Intravitreal Anti-Complement Factor 3 (C3) Products for the Treatment of Dry AMD and Other Retinal Diseases

Collaboration aims to develop best-in-class anti-C3 intravitreal products with quarterly dosing frequency and better potency C3 is a clinically validated target in dry age-related macular degener...

PubMed Articles [67 Associated PubMed Articles listed on BioPortfolio]

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Amnesia and criminal responsibility.

Front cover.

Front cover.

Back cover.

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.

The purpose of this multi-center study is to obtain clinical data to substantiate that Aastrom TRC autologous bone marrow cells will regenerate bone in patients with established (appendicu...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion

The hypothesis is that Aastrom TRC autologous bone marrow tissue "grafts" can be safely used to promote bone healing as part of a single level posterolateral spine fusion surgical procedur...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [380 Associated Companies listed on BioPortfolio]

Aastrom Biosciences, Inc.

Founded in 1989 and with headquarters in Ann Arbor, Michigan, Aastrom Biosciences is dedicated to the development of stem cell treatments for critical cardiovascular diseases. Aastrom is currently e...

Aastrom Biosciences Incorporated

Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for c...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Aastrom Biosciences Incorporated" on BioPortfolio

We have published hundreds of Aastrom Biosciences Incorporated news stories on BioPortfolio along with dozens of Aastrom Biosciences Incorporated Clinical Trials and PubMed Articles about Aastrom Biosciences Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aastrom Biosciences Incorporated Companies in our database. You can also find out about relevant Aastrom Biosciences Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...


Corporate Database Quicklinks



Searches Linking to this Company Record